Kalshi is Betting on Trial Results and FDA Decisions Now, What's Next?
FDA Announces 3 Final Guidances to Increase Patient Participation in Oncology Trials
Evis Sala Announces a Landmark Oncology Partnership Between Albania and Italy
RxPONDER Analysis: Ovarian Reserve May Refine Chemotherapy Decisions in HR-Positive Breast Cancer
SABCS 2026 Male Breast Cancer Advocate Scholarship
First Chemotherapy Session: What to Expect
Herbert Loong: Prospective Open-labelled Phase 2 Pembrolizumab in Acral Lentiginous Melanoma
Wafik El-Deiry: Scientific Freedom and Diverse Thinking Drive Better Medicine
Classifies metastatic renal cell carcinoma (RCC) prognosis using IMDC (International Metastatic RCC Database Consortium) criteria.
Check if YES (risk factor), leave unchecked if NO
Check if YES (risk factor), leave unchecked if NO
Check if YES (risk factor), leave unchecked if NO
Check if YES (risk factor), leave unchecked if NO
Check if YES (risk factor), leave unchecked if NO
Check if YES (risk factor), leave unchecked if NO
IMDC Risk Factors:
Risk Categories:
LLN = Lower Limit of Normal, ULN = Upper Limit of Normal
